I think it is pretty evident that the pushing back of the trial end date is not for the 106 patients. The patients are readily available, the trial has started per the 10Q, and there is only a 29 day follow up after dosing to end of trial. It will be over, if not already, within a matter of a few weeks.
If trial goes until Sept, it will for a lot of other uses of B in regards to viruses (most likely other coronaviruses), and those results will not be part of the current trial.
My opinion only.
News 
Market Data 
Discover 
AI
